 Ethambutol
"Ethambutol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antitubercular agent that inhibits the transfer of mycolic acids into the cell wall of the tubercle bacillus. It may also inhibit the synthesis of spermidine in mycobacteria. The action is usually bactericidal, and the drug can penetrate human cell membranes to exert its lethal effect. (From Smith and Reynard, Textbook of Pharmacology, 1992, p863)
| Descriptor ID |
D004977
|
| MeSH Number(s) |
D02.092.782.258.368.265
|
| Concept/Terms |
EMB-Hefa- EMB-Hefa
- EMB Hefa
- Wernigerode Brand of Ethambutol Hydrochloride
- Sanavita Brand of Ethambutol Hydrochloride
Etambutol Llorente- Etambutol Llorente
- Llorente, Etambutol
- Llorente Brand of Ethambutol Hydrochloride
Etibi- Etibi
- Fatol Brand of Ethambutol Hydrochloride
- EMB-Fatol
- EMB Fatol
- ICN Brand of Ethambutol Hydrochloride
Myambutol- Myambutol
- Elan Brand of Ethambutol Hydrochloride
- Miambutol
- Lederle Brand of Ethambutol Hydrochloride
- Riemser Brand of Ethambutol Hydrochloride
- Wyeth Brand of Ethambutol Hydrochloride
- AHP Brand of Ethambutol Hydrochloride
- Genopharm Brand of Ethambutol Hydrochloride
Dexambutol- Dexambutol
- SERB Brand of Ethambutol Hydrochloride
|
Below are MeSH descriptors whose meaning is more general than "Ethambutol".
Below are MeSH descriptors whose meaning is more specific than "Ethambutol".
This graph shows the total number of publications written about "Ethambutol" by people in UAMS Profiles by year, and whether "Ethambutol" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 | | 2013 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 | | 2006 | 1 | 1 | 2 | | 2005 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ethambutol" by people in Profiles over the past ten years.
-
Dawson R, Diacon AH, Everitt D, van Niekerk C, Donald PR, Burger DA, Schall R, Spigelman M, Conradie A, Eisenach K, Venter A, Ive P, Page-Shipp L, Variava E, Reither K, Ntinginya NE, Pym A, von Groote-Bidlingmaier F, Mendel CM. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis. Lancet. 2015 May 02; 385(9979):1738-1747.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|